Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems

Launched by IRCCS SAN RAFFAELE · Feb 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment for people with blood clots in the veins of the pelvis or legs, known as deep vein thrombosis (DVT). The goal is to see how well a procedure called mechanical thrombectomy works in removing these clots, specifically in adults who have been diagnosed with this condition through a CT scan. The trial will look at real-life experiences in a specific hospital setting to understand how effective and safe this treatment can be.

To join the study, participants must be adults who are admitted to the vascular surgery unit with specific types of DVT. However, some people may not be eligible, such as those who have had certain treatments for blood clots very recently, are currently bleeding, or cannot give consent to participate. Those who take part in the trial can expect to receive care according to standard medical practices, and the findings could help improve treatments for DVT in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients admitted in the Unit of Vascular Surgery with proximal DVT (inferior vena cava, and/or iliac vein, and/or common femoral vein, and/or deep femoral vein, and/or femoral vein), according to ESVS guidelines (2022).
• Exclusion Criteria:
• • Patient treated with thrombolysis drugs within 48 hours prior to the index procedure
• • Active bleeding, recent (\<3 months) gastrointestinal (GI) bleeding, active peptic ulcer, severe liver dysfunction, and bleeding diathesis
• • Impossibility or refusal to give informed consent